Structure and function of human plasma carboxypeptidase N, the anaphylatoxin inactivator

被引:48
作者
Skidgel, Randal A. [1 ]
Erdos, Ervin G. [1 ]
机构
[1] Univ Illinois, Coll Med, Dept Pharmacol & Anesthesiol, Chicago, IL 60612 USA
关键词
human carboxypeptidase N; bradykinin; anaphylatoxins; plasmin; protein structure; proteolysis;
D O I
10.1016/j.intimp.2007.07.014
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Human carboxypeptidase N (CPN) was discovered in the early 1960s as a plasma enzyme that inactivates bradykinin and was identified 8 years later as the major "anaphylatoxin inactivator" of blood. CPN plays an important role in protecting the body from excessive buildup of potentially deleterious peptides that normally act as local autocrine or paracrine hormones. This review summarizes the structure, enzymatic properties and function of this important human enzyme, including insights gained by the recent elucidation of the crystal structure of the CPN catalytic subunit and structural modeling of the non-catalytic regulatory 83 kDa subunit. We also discuss its physiological role in cleaving substrates such as kinins, anaphylatoxins, creatine kinase, plasminogen receptors, hemoglobin and stromal cell-derived factor- 1 alpha (SDF- 1 alpha). (c) 2007 Elsevier B.V All rights reserved.
引用
收藏
页码:1888 / 1899
页数:12
相关论文
共 95 条
[1]   Carboxypeptidase I. The preparation of crystalline carboxypeptidase [J].
Anson, ML .
JOURNAL OF GENERAL PHYSIOLOGY, 1937, 20 (05) :663-669
[2]  
BHOOLA KD, 1992, PHARMACOL REV, V44, P1
[3]   ANAPHYLATOXIN INACTIVATOR OF HUMAN PLASMA - ITS ISOLATION AND CHARACTERIZATION AS A CARBOXYPEPTIDASE [J].
BOKISCH, VA ;
MULLEREB.HJ .
JOURNAL OF CLINICAL INVESTIGATION, 1970, 49 (12) :2427-&
[4]   ISOLATION OF A FRAGMENT (C3A) OF THIRD COMPONENT OF HUMAN COMPLEMENT CONTAINING ANAPHYLATOXIN AND CHEMOTACTIC ACTIVITY AND DESCRIPTION OF AN ANAPHYLATOXIN INACTIVATOR OF HUMAN SERUM [J].
BOKISCH, VA ;
MULLEREB.HJ ;
COCHRANE, CG .
JOURNAL OF EXPERIMENTAL MEDICINE, 1969, 129 (05) :1109-&
[5]   Thrombin-activatable fibrinolysis inhibitor (TAFI, plasma procarboxypeptidase B, procarboxypeptidase R, procarboxypeptidase U) [J].
Bouma, BN ;
Marx, PF ;
Mosnier, LO ;
Meijers, JCM .
THROMBOSIS RESEARCH, 2001, 101 (05) :329-354
[6]   DNA polymorphism and mutations in CPN1, including the genomic basis of carboxypeptidase N deficiency [J].
Cao, H ;
Hegele, RA .
JOURNAL OF HUMAN GENETICS, 2003, 48 (01) :20-22
[7]   CARBOXYPEPTIDASE-N (KININASE-I) ACTIVITY IN BLOOD AND SYNOVIAL-FLUID FROM PATIENTS WITH ARTHRITIS [J].
CHERCUITTE, F ;
BEAULIEU, AD ;
POUBELLE, P ;
MARCEAU, F .
LIFE SCIENCES, 1987, 41 (10) :1225-1232
[8]  
COLMAN RW, 1987, ANESTHESIOLOGY, V66, P595
[9]   Identification of carboxypeptidase N as an enzyme responsible for C-terminal cleavage of stromal cell-derived factor-1α in the circulation [J].
Davis, DA ;
Singer, KE ;
Sierra, MD ;
Narazaki, M ;
Yang, FQ ;
Fales, HM ;
Yarchoan, R ;
Tosato, G .
BLOOD, 2005, 105 (12) :4561-4568
[10]   ENHANCED CO-2+ ACTIVATION AND INHIBITOR BINDING OF CARBOXYPEPTIDASE-M AT LOW PH - SIMILARITY TO CARBOXYPEPTIDASE-H (ENKEPHALIN CONVERTASE) [J].
DEDDISH, PA ;
SKIDGEL, RA ;
ERDOS, EG .
BIOCHEMICAL JOURNAL, 1989, 261 (01) :289-291